Tags

Type your tag names separated by a space and hit enter

Regulation of natural health products in Canada.
J Ethnopharmacol. 2014 Dec 02; 158 Pt B:507-10.JE

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE/INTRODUCTION

In Canada, all natural health products (NHPs) are regulated by Health Canada (HC) under the Food and Drugs Act and the Natural Health Product Regulations. All authorized products undergo pre-market assessment for safety, efficacy and quality and the degree of pre-market oversight varies depending on the risk of the product.

OVERVIEW

In Canada, over 70,000 products have been authorized for sale and over 2000 sites have been licensed to produce NHPs. In the management of NHPs on the Canadian market, HC employs a number of active and collaborative methods to address the most common issues such as contamination, adulteration and deceptive or misleading advertising practices. HC is currently evolving its approaches to NHPs to recognize them as part of the larger group of health products available without a prescription. As such, the regulatory responsibility for all over-the-counter (OTC) drugs, including non-prescription drugs and NHPs, has been transferred to a single federal division.

CONCLUSION

As a result of this transition a number of benefits are being realized with respect to government efficiency, clarity for industry, support for new innovations and consolidated government interactions with the Canadian market.

Authors+Show Affiliations

Natural Health Products Directorate, Health Products Food Branch, Health Canada, 2936 Baseline Road, Postal Locator 3301A, Ontario, Ottawa, Canada(1).Natural Health Products Directorate, Health Products Food Branch, Health Canada, 2936 Baseline Road, Postal Locator 3301A, Ontario, Ottawa, Canada(1). Electronic address: Sumedha.jogalekar@hc-sc.gc.ca.Natural Health Products Directorate, Health Products Food Branch, Health Canada, 2936 Baseline Road, Postal Locator 3301A, Ontario, Ottawa, Canada(1).

Pub Type(s)

Journal Article

Language

eng

PubMed ID

24969823

Citation

Smith, Alysyn, et al. "Regulation of Natural Health Products in Canada." Journal of Ethnopharmacology, vol. 158 Pt B, 2014, pp. 507-10.
Smith A, Jogalekar S, Gibson A. Regulation of natural health products in Canada. J Ethnopharmacol. 2014;158 Pt B:507-10.
Smith, A., Jogalekar, S., & Gibson, A. (2014). Regulation of natural health products in Canada. Journal of Ethnopharmacology, 158 Pt B, 507-10. https://doi.org/10.1016/j.jep.2014.06.037
Smith A, Jogalekar S, Gibson A. Regulation of Natural Health Products in Canada. J Ethnopharmacol. 2014 Dec 2;158 Pt B:507-10. PubMed PMID: 24969823.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Regulation of natural health products in Canada. AU - Smith,Alysyn, AU - Jogalekar,Sumedha, AU - Gibson,Adam, Y1 - 2014/06/24/ PY - 2014/03/14/received PY - 2014/05/20/revised PY - 2014/06/12/accepted PY - 2014/6/28/entrez PY - 2014/6/28/pubmed PY - 2016/1/9/medline KW - Canada KW - Herbal medicine KW - Monograph KW - Natural health products KW - Regulation SP - 507 EP - 10 JF - Journal of ethnopharmacology JO - J Ethnopharmacol VL - 158 Pt B N2 - ETHNOPHARMACOLOGICAL RELEVANCE/INTRODUCTION: In Canada, all natural health products (NHPs) are regulated by Health Canada (HC) under the Food and Drugs Act and the Natural Health Product Regulations. All authorized products undergo pre-market assessment for safety, efficacy and quality and the degree of pre-market oversight varies depending on the risk of the product. OVERVIEW: In Canada, over 70,000 products have been authorized for sale and over 2000 sites have been licensed to produce NHPs. In the management of NHPs on the Canadian market, HC employs a number of active and collaborative methods to address the most common issues such as contamination, adulteration and deceptive or misleading advertising practices. HC is currently evolving its approaches to NHPs to recognize them as part of the larger group of health products available without a prescription. As such, the regulatory responsibility for all over-the-counter (OTC) drugs, including non-prescription drugs and NHPs, has been transferred to a single federal division. CONCLUSION: As a result of this transition a number of benefits are being realized with respect to government efficiency, clarity for industry, support for new innovations and consolidated government interactions with the Canadian market. SN - 1872-7573 UR - https://www.unboundmedicine.com/medline/citation/24969823/Regulation_of_natural_health_products_in_Canada_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0378-8741(14)00485-1 DB - PRIME DP - Unbound Medicine ER -